GDOC:NYE-Goldman Sachs ETF Trust (USD)

ETF | Others |

Last Closing

USD 33.4469

Change

-0.53 (-1.56)%

Market Cap

USD 0.02B

Volume

470.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The fund invests, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes (measured at the time of purchase) in equity investments in U.S. and non-U.S. health care companies. The adviser generally intends to invest in companies that the adviser believes are aligned with key themes associated with innovation in health care, which include, but are not limited to, genomics, precision medicine, technology-enabled procedures, and digital healthcare. The fund is non-diversified.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-14 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SOJE Southern Company (The) Series ..

-0.04 (-0.20%)

USD 65.72B
JEPI JPMorgan Equity Premium Income..

-0.24 (-0.40%)

USD 36.47B
DFAC Dimensional U.S. Core Equity 2..

-0.23 (-0.64%)

USD 31.32B
JPST JPMorgan Ultra-Short Income ET..

N/A

USD 26.94B
SGOV iShares® 0-3 Month Treasury B..

N/A

USD 26.72B
DTB DTE Energy Company 2020 Series

-0.14 (-0.71%)

USD 26.58B
GBTC Grayscale Bitcoin Trust (BTC)

-1.81 (-2.54%)

USD 15.23B
AVUV Avantis® U.S. Small Cap Value..

-0.64 (-0.62%)

USD 14.03B
JAAA Janus Detroit Street Trust - J..

+0.04 (+0.08%)

USD 13.91B
CGDV Capital Group Dividend Value E..

-0.30 (-0.82%)

USD 11.53B

ETFs Containing GDOC

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.27% 35% F 37% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.27% 17% F 26% F
Trailing 12 Months  
Capital Gain 13.21% 51% F 51% F
Dividend Return 0.61% 8% B- 6% D-
Total Return 13.82% 46% F 43% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 2.47% 57% F 43% F
Dividend Return 2.47% 50% F 35% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 7.75% 64% D 85% B
Risk Adjusted Return 31.87% 47% F 48% F
Market Capitalization 0.02B 33% F 12% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.